SCHEMBL14921080

SCHEMBL14921080

O=C(O)C(F)(F)c1ncc(Cl)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PLAU P00749 1/20 0.36
▸ HCAR2 Q8TDS4 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CCR9 P51686 1/20 0.34
▸ TRPM8 Q7Z2W7 2/20 0.34
▸ TSHR P16473 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ DHODH Q02127 1/20 0.33
▸ ATF1 P18846 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ PDK2 Q15119 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14921072 0.83 GLA (0.52) LMNAPLAUGLAHPGDSMN1; SMN2
SCHEMBL10671281 0.77 LMNA (0.41) LMNAL3MBTL1PLAUHCAR2CCR9
SCHEMBL14932583 0.77 L3MBTL1 (0.41) L3MBTL1HPGDTSHRSMN1; SMN2HTT
SCHEMBL17964135 0.77 HTT (0.43) LMNAL3MBTL1PLAUHPGDTSHR
SCHEMBL21994824 0.73 CYP2C9 (0.37) LMNAL3MBTL1PLAUTSHRSMN1; SMN2
SCHEMBL14921130 0.73 LMNA (0.39) LMNAL3MBTL1PLAUHPGDTRPM8
SCHEMBL23119566 0.71 ASPH (0.45) HCAR2CCR9DHODHATF1NFKB1
SCHEMBL27176554 0.70 ALK (0.39) LMNAL3MBTL1GLAHPGDCCR9
SCHEMBL30707926 0.70 ALK (0.39) LMNAL3MBTL1GLAHPGDCCR9
SCHEMBL31410031 0.70 PLAU (0.42) LMNAL3MBTL1PLAUTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9301526-B2 Compounds with nematicidal activity BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-04-05 — — US disclosed
US-20140256728-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-09-11 — — US disclosed
EP-2773215-A2 COMPOUNDS WITH NEMATICIDAL ACTIVITY Bayer Intellectual Property GmbH (DE) 2014-09-10 — — EP disclosed
EP-2773203-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY Bayer Intellectual Property GmbH (DE) 2014-09-10 — — EP disclosed
US-20140249149-A1 Compounds with Nematicidal Activity BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-09-04 — — US disclosed
EP-2606728-A1 Compounds with nematicidal activity Bayer CropScience AG (DE) 2013-06-26 — — EP disclosed
EP-2606727-A1 Compounds with nematicidal activity Bayer CropScience AG (DE) 2013-06-26 — — EP disclosed
WO-2013064460-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-10 — — WO disclosed
WO-2013064461-A2 COMPOUNDS WITH NEMATICIDAL ACTIVITY BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256728-A1 COMPOUNDS WITH NEMATICIDAL ACTIVITY ACHE, TUBA3C, NAAA LMNA 1026/4885L3MBTL1 894/4885PLAU 3610/4885
US-20140249149-A1 Compounds with Nematicidal Activity ACHE, NAAA, TUBA3C LMNA 1201/4885L3MBTL1 1501/4885PLAU 3521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback